Skip to main content
Log in

A randomized two stage allocation for continuous response clinical trials

  • Published:
Statistical Methods & Applications Aims and scope Submit manuscript

Abstract

A randomized two treatment allocation design, conducted in two stages, is proposed for a class of continuous response trials. Patients are assigned to each treatment in equal numbers in the first stage and p value of a test of equality of treatment effects based on these data is used to determine the assignment probability of second stage patients. Relevant properties of the proposed allocation design are investigated and compared with suitable competitors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Antognini AB, Giovagnoli A (2005) On the large sample optimality of sequential designs for comparing two or more treatments. Seq Anal 24:205–217

    Article  MATH  Google Scholar 

  • Bandyopadhyay U, Bhattacharya R (2006) An optimal sequential procedure in ethical allocation. J Stat Plan Inference 136:430–446

    Article  MATH  MathSciNet  Google Scholar 

  • Bandyopadhyay U, Bhattacharya R (2007) On an ethical cum optimal adaptive allocation design. Statistics 41:471–483

    Article  MATH  MathSciNet  Google Scholar 

  • Bandyopadhyay U, Biswas A (2001) Adaptive designs for normal responses with prognostic factors. Biometrika 88:409–419

    Article  MATH  MathSciNet  Google Scholar 

  • Biswas A, Bhattacharya R (2009) Optimal response-adaptive designs for normal responses. Biom J 51:193–202

    Article  MathSciNet  Google Scholar 

  • Biswas A, Mandal S (2004) Optimal adaptive designs in phase III clinical trials for continuous responses with covariates. In: Bucchianico ADi, Lauter H, Wynn HP (eds) mODa 7: advances in model-oriented design and analysis. Physica-Verlag, Heidelberg, pp 51–58

  • Billingsley P (1995) Probability and measure, 3rd edn. Wiley, New York

    MATH  Google Scholar 

  • Coad DS (1992) Some results on estimation for two stage clinical trials. Seq Anal 11:299–311

    Article  MATH  MathSciNet  Google Scholar 

  • Colton T (1963) A model for selecting one of two medical treatments. J Am Stat Assoc 58:388–400

    Article  MathSciNet  Google Scholar 

  • Hu F, Rosenberger WF (2006) The theory of response-adaptive randomization in clinical trials. Wiley Interscience, New York

    Book  MATH  Google Scholar 

  • Lehmann EL, Romano JP (2005) Testing statistical hypotheses, 3rd edn. Springer, New York

    MATH  Google Scholar 

  • Rosenberger WF (1993) Asymptotic inference with response-adaptive treatment allocation designs. Ann Stat 21:2098–2107

    Article  MATH  MathSciNet  Google Scholar 

  • Rosenberger WF, Lachin JL (2002) Randomisation in clinical trials: theory and practice. Wiley, New York

    Book  Google Scholar 

  • Zhang L, Rosenberger WF (2006) Response-adaptive randomization for clinical trials with continuous outcomes. Biometrics 62:562–569

    Article  MATH  MathSciNet  Google Scholar 

  • Zhang LX, Rosenberger WF (2011) Optimal response-adaptive randomization for clinical trials. In: Pong A, Shein-Chung C (eds) Handbook of adaptive designs in pharmaceutical and clinical development, Chapter 15. CRC Press, Boca Raton

    Google Scholar 

Download references

Acknowledgments

The authors would like to thank the anonymous reviewers, the editor and the associate editor for their concerns and insightful comments which led to an improvement over the earlier version of the work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rahul Bhattacharya.

Appendix

Appendix

Result 4.1

Suppose the response to treatment k has a normal distribution with mean \(\mu _{k}\) and variance \(\sigma _{k}^2\). Then, under any \({{\varvec{\xi }}}=(\mu _A,\mu _B,\sigma _A,\sigma _B)\) with \(\mu _A\ne \mu _B,\) as \(m\rightarrow \infty \)

$$\begin{aligned} p_{m}\rightarrow 1 \text{ or } 0 \end{aligned}$$

in probability, according as \(\mu _{A}>\) or \(<\mu _{B}\).

Proof

Consider two statistics \(T_{0m}\) and \(T_{1m}\) where the distribution of \(T_{0m}\) under any \({{\varvec{\xi }}}\) is the same as that of \(T_{m}\) under \(\mu _A=\mu _B.\) Further the distributions of \(T_{1m}\) and \(T_{m}\) are identical under any \({{\varvec{\xi }}}\). Then \(p_m\) can be expressed as \(p_m=P_{\varvec{\xi }}(T_{0m}\ge T_{1m})\). Since the first stage of the allocation design results in independent and identically distributed observations, it follows from the strong law of large numbers (Chapter 6, Billingsley 1995) that as \(m\rightarrow \infty \)

$$\begin{aligned} \bar{X}_{km}\rightarrow \mu _{k} \text{ and } s^{2}_{km}\rightarrow \sigma _{k}^{2} \end{aligned}$$

almost surely. Therefore, for any \({{\varvec{\xi }}}\),

$$\begin{aligned} \frac{T_{0m}}{\sqrt{m}}-\frac{T_{1m}}{\sqrt{m}}\rightarrow \frac{\mu _B-\mu _A}{\sqrt{\sigma _{A}^{2}+\sigma _{B}^{2}}} \end{aligned}$$

almost surely and consequently, as \(m\rightarrow \infty \)

$$\begin{aligned} p_m=P_{\varvec{\xi }}\left( \frac{T_{0m}}{\sqrt{m}}- \frac{T_{1m}}{\sqrt{m}}\ge 0\right) \rightarrow 1 \text{ or } 0 \end{aligned}$$

in probability according as \(\mu _{A}>\) or \(<\mu _{B}.\) Hence the result follows. \(\square \)

Note

If the response to treatment k has an exponential distribution with mean \(\mu _{k}\), then for any \((\mu _{A},\mu _{B})\)

$$\begin{aligned} \frac{T_{0m}}{T_{1m}}\rightarrow \frac{\mu _B}{\mu _A} \end{aligned}$$

almost surely, as \(m\rightarrow \infty .\) The rest of the proof is exactly the same as above with \({\varvec{\xi }}=(\mu _{A},\mu _{B})\).

Result 4.2

If (2.3) holds, then under any \({{\varvec{\xi }}}\) with \(\mu _A\ne \mu _B,\) as \(n\rightarrow \infty \)

$$\begin{aligned} \frac{N_{An}}{n}\rightarrow 1-\theta \text{ or } \theta \end{aligned}$$

in probability, according as \(\mu _{A}>\) or \(<\mu _{B}\).

Proof

Assume \(\mu _{A}>\mu _B\). Then it follows from Result 1 that as \(m\rightarrow \infty \)

$$\begin{aligned} p_{m}\rightarrow 0 \end{aligned}$$

in probability. Then from (2.1) and (2.2) it follows easily that

$$\begin{aligned} E_{\varvec{\xi }}\left( \frac{N_{An}}{n}\right) \rightarrow 1-\theta \end{aligned}$$

and

$$\begin{aligned} Var_{\varvec{\xi }}\left( \frac{N_{An}}{n}\right) \rightarrow 0. \end{aligned}$$

as \(n\rightarrow \infty \). Consequently, as \(n\rightarrow \infty \)

$$\begin{aligned} \frac{N_{An}}{n}\rightarrow 1-\theta \end{aligned}$$

in probability. A similar argument leads to the proof with \(\mu _A<\mu _B\). This completes the proof. \(\square \)

Note

The above result holds good for the exponentially distributed responses if we redefine \({\varvec{\xi }}=(\mu _{A},\mu _{B})\).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhattacharya, R., Shome, M. A randomized two stage allocation for continuous response clinical trials. Stat Methods Appl 24, 373–386 (2015). https://doi.org/10.1007/s10260-014-0267-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10260-014-0267-6

Keywords

Navigation